期刊文献+

老年直肠癌术后辅助化疗相关病理特征及预后多因素分析 被引量:1

Postoperative adjuvant chemotherapy related pathological characteristics of elderly rectal cancer and multivariate analysis of prognosis
原文传递
导出
摘要 目的探讨老年直肠癌术后辅助化疗相关病理特征及预后多因素分析。方法回顾性分析2007年1月至2010年1月收治的200例老年直肠癌患者临床资料,包括姓名、年龄、性别、主诉症状、症状出现及持续时间、术前癌胚抗原(CEA)、手术日期、手术方式、TNM分期、病理分化程度、肿瘤部位、大小、淋巴结转移情况、肿瘤浸润情况、淋巴结检出数目、放化疗方案及时间、术后复发及转移情况等一般资料。采用Kaplan-Meier法计算生存率,Long-Rank法对影响其预后的相关因素进行单因素分析,同时将经单因素分析为预后危险因素纳入多因素Cox回归模型分析。结果本组200例患者,术后3、5年总生存率分别为80.63%和73.75%。肿瘤直径>5 cm、肿瘤低分化、浸润深度、TNM分期Ⅲ期、淋巴结转移、术前CEA>10 ng/m L及术后是否行辅助化疗是影响患者预后的危险因素。将以上7项指标进行多因素Cox回归分析发现,肿瘤直径>5 cm、肿瘤低分化、TNM分期Ⅲ期、淋巴结转移、术前CEA>10 ng/m L是影响患者预后的独立危险因素(P<0.05)。结论肿瘤直径>5 cm、肿瘤低分化、TNM分期Ⅲ期、淋巴结转移及术前CEA>10 ng/m L是影响患者预后的独立危险因素,而对于存在淋巴结转移及术前CEA>10 ng/m L的高危患者可考虑术后辅助化疗。 Objective To investigate the pathological characteristics related to postoperative adjuvant chemotherapy of elderly rectal cancer and analyze the prognostic factors. Methods Clinical data of 200 elderly patients with rectal cancer treated in our hospital during Jan. 2007 and Jan. 2010 were retrospectively review ed. Patient's age,gender,complaints,duration of symptoms,preoperative( carcino-embryonic antigen CEA),date of surgery,surgical procedure,TNMstage,pathological differentiation,tumor location,size,lymph node metastasis,tumor invasion,number of examined lymph nodes,rehabilitation plan and time,postoperative recurrence and metastasis were analyzed. KaplanMeier method was employed to calculate the survival rate,Long-Rank test was adopted to analyze single prognostic factor,and Cox regression analysis was performed to assess the multi- factors. Results The postoperative 3-year and5-year survival rates were 80. 63% and 73. 75%. Tumor diameter〉 5 cm,poor tumor differentiation,TNMstage Ⅲ,lymph node metastasis,and preoperative CEA 〉10 ng/m L were the independent risk factors of prognosis. Conclusion Tumor diameter 〉5 cm,low tumor differentiation,TNMstage Ⅲ,lymph node metastasis,and preoperative CEA 〉10 ng/m L are the independent risk factors affecting the prognosis,and patients with lymph node metastasis and preoperative CEA 〉10 ng/m L had better receive adjuvant chemotherapy after operation.
出处 《山东大学学报(医学版)》 CAS 北大核心 2016年第1期48-51,共4页 Journal of Shandong University:Health Sciences
关键词 直肠肿瘤 辅助化疗 病理特征 预后 Rectal noeplasm Adjuvant chemotherapy Pathological features Prognosis
  • 相关文献

参考文献12

二级参考文献144

  • 1邱云峰,陈虹,任重,廖芝伟.青年人大肠癌的临床特点及外科治疗[J].中国普通外科杂志,2006,15(2):153-154. 被引量:10
  • 2Plainer G, Martling A, Gedemark B, et al. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol, 2007,14(2):447-454.
  • 3Wong CS, Cumming BJ, Brierly JD, et al. Treatment of locally recurrent rectal carcinoma--results and prognostic factors. Int J Radiat Oncol Bio Phys, 1998,40(2):427-435.
  • 4Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer, 1995,75 (4) : 939-952.
  • 5Kakuda JT, Lamont JP, Chu DZ, et al. The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg, 2003,186 (6) : 660-664.
  • 6Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg, 2003,237(4) :502-508.
  • 7Sagar PM, Gonsalves S, Heath RM, et al. Composite abdominosacral resection for recurrent rectal cancer. Br J Surg, 2009,96(2) : 191-196.
  • 8Maetani S, Onodera H, Nishikawa T. Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Dis Colon Rectum, 2007,50(10) : 1558-1567.
  • 9Vermaas M, Ferenschild FT, Verhoef C, et al. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol, 2007,33 (4) : 452-458.
  • 10Caricato M, Borzomati D, Ausania F, et al. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Ear J Sarg Oncol, 2006,32(2) : 126-132.

共引文献114

同被引文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部